Related Experiment Video
Updated: Apr 21, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
p53 suppresses 14-3-3γ by stimulating proteasome-mediated 14-3-3γ protein degradation
De-Yu Chen1, Dong-Fang Dai1, Ye Hua1
1Institute of Oncology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China.
Abstract:
14-3-3 proteins are a family of highly conserved polypeptides that interact with a large number of proteins and play a role in a wide variety of cellular processes. 14-3-3 proteins have been demonstrated overexpressed in several cancers and serving as potential oncogenes. In a previous study we showed one isoform of the 14-3-3 family, 14-3-3γ was negatively regulated by p53 through binding to its promoter and inhibiting its transcription. In the present study we investigated both p53 and 14-3-3γ protein levels in human lung cancerous tissues and normal lung tissues. We found 14-3-3γ expression correlated to p53 overexpression in lung cancer tissues. Ecotopic expression of wild-type p53, but not mutant p53 (R175H) suppressed both endogenous and exogenous 14-3-3γ in colon and lung cancer cell lines. Further examination demonstrated that p53 interacted with C-terminal domain of 14-3-3γ and induced 14-3-3γ ubiquitination. MG132, a specific inhibitor of the 26S proteasome, could block the effect of p53 on 14-3-3γ protein levels, suggesting that p53 suppressed 14-3-3γ by stimulating the process of proteasome-mediated degradation of 14-3-3γ. These results indicate that the inhibitory effect of p53 on 14-3-3γ is mediated also by a post-transcriptional mechanism. Loss of p53 function may result in upregulation of 14-3-3γ in lung cancers.
Insights
The tumor suppressor p53 protein degrades the oncogenic 14-3-3 gamma protein through a post-transcriptional mechanism. Loss of p53 function in lung cancer may lead to increased 14-3-3 gamma levels.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Biology
Background:
- 14-3-3 proteins are highly conserved and involved in numerous cellular processes.
- Overexpression of 14-3-3 proteins is observed in various cancers, suggesting oncogenic roles.
- Previous work indicated p53 negatively regulates 14-3-3 gamma transcription.
Purpose of the Study:
- Investigate p53 and 14-3-3 gamma protein levels in lung cancer.
- Determine the mechanism by which p53 affects 14-3-3 gamma expression.
- Explore the role of p53-mediated regulation of 14-3-3 gamma in lung cancer.
Main Methods:
- Analysis of p53 and 14-3-3 gamma protein levels in human lung tissues.
- Ectopic expression of wild-type and mutant p53 in cancer cell lines.
- Co-immunoprecipitation to study protein interactions.
- Ubiquitination assays and proteasome inhibition studies (MG132).
Main Results:
- 14-3-3 gamma expression correlates with p53 overexpression in lung cancer tissues.
- Wild-type p53, but not mutant p53 (R175H), suppresses 14-3-3 gamma levels in cancer cells.
- p53 interacts with the C-terminal domain of 14-3-3 gamma, inducing its ubiquitination.
- Proteasome inhibitor MG132 blocks p53's effect, indicating proteasome-mediated degradation.
Conclusions:
- p53 suppresses 14-3-3 gamma protein levels via a post-transcriptional mechanism involving proteasome-mediated degradation.
- This regulation pathway is active in lung cancer.
- Loss of p53 function in lung cancer could lead to 14-3-3 gamma upregulation and potential oncogenesis.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

